XP21279

· XenoPort, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XP21279, covering 2021-02-18 to 2021-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects [Phase 2]